When transgender children cannot access puberty blockers, they will experience the puberty associated with their birth-assigned sex, which can result in permanent physical changes that may not align with their gender identity. Research shows that this can have significant psychological and social impacts for young people who are exploring their gender.
Evidence indicates that for transgender girls (assigned male at birth), going through male puberty leads to the development of characteristics such as a deeper voice, prominent Adam's apple, increased height and bone structure, broader hands and feet, facial and body hair growth, and more masculine facial features. Similarly, transgender boys (assigned female at birth) may develop breast tissue, wider hips, and other secondary sexual characteristics that can cause distress. Guidelines from major medical organisations recognise that these changes are largely irreversible and can contribute to gender dysphoria and mental health challenges.
Medical professionals explain that puberty blockers function as a temporary pause button, allowing young people and their families time to explore gender identity without the pressure of irreversible physical changes occurring. The medication is reversible, meaning that if discontinued, typical pubertal development will resume. Without this intervention, the physical changes of puberty become permanent features that may require more complex medical interventions later in life.
People often ask about the long-term implications, and evidence suggests that early intervention can significantly improve quality of life outcomes. The decision to use puberty blockers involves careful consideration between young people, families, and healthcare teams, weighing the benefits of preventing distressing physical changes against other factors in each individual case.